M
Mineralys Therapeutics, Inc.
MLYS · NASDAQ · Healthcare · 2.3B
Price · close
$25.65
-0.39% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.7×
Enterprise value / EBITDAEV/EBITDA
-10.1×
Free cash flow yieldFCF yield
-8.2%
Return on equityROE
-23.9%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
1.1×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.